Cloud infrastructures for in silico drug discovery: economic and practical aspects.

Cloud computing opens new perspectives for small-medium biotechnology laboratories that need to perform bioinformatics analysis in a flexible and effective way. This seems particularly true for hybrid clouds that couple the scalability offered by generalpurpose public clouds with the greater control...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International Vol. 2013; pp. 138012 - 138013
Autores principales: D'Agostino, Daniele, Clematis, Andrea, Quarati, Alfonso, Cesini, Daniele, Chiappori, Federica, Milanesi, Luciano, Merelli, Ivan
Formato: Journal Article
Publicado: Wiley-Blackwell 2013
Acceso en línea:Ver este registro en EBSCOhost